Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On June 30, 2022, US Nuclear Corp, a Delaware corporation (the "Company")
received notice of resignation by its Chief Financial Officer, Rachel Boulds.
Ms. Boulds' resignation did not result from any disagreement with the Company.
On the same day, the Company appointed its Chief Opperating Officer, Richard
Landry, to serve as the Chief Financial Officer of the Company effective as of
June 30, 2022. Mr. Landry's compensation will not be altered as a result of his
appointment to CFO. Mr. Landry is 26 years old.
Mr. Landry's biographical information follows:
Richard Landry - Chief Financial Officer, Chief Operating Officer, Director of
Investor Relations and Business Development Consultant. Mr. Landry began his
career in the financial world as a proprietary trader while in college; majoring
in Mathematics and Applied Physics. Through an investment banking internship,
Mr. Landry furthered his experience in Finance, which eventually lead him to
vSource 1 Capital, where he spear-headed the business development, marketing and
assisted in structuring capital for public and private companies. This included
advising, marketing, sourcing, evaluating, and conducting due diligence on new
opportunities. Mr. Landry has been instrumental in assisting in
raising/structuring almost $1.5B worth in new capital & deal flow. He has
built-out and devised algorithms/trading strategies for top hedge funds,
implemented CRMs for emerging tech companies, established sales growth
strategies while maintaining regulatory requirements, worked with some of the
largest asset management firms in the world such as; Fosun International and
CIM, and was the Chief Compliance Officer of a Chinese tech firm where he
assisted in their $150 million capital raise, as well as maintaining their
compliance with China's One Belt One Road Initiative. His responsibilities at US
Nuclear Corp include marketing, research on new technologies, oversight of
day-to-day activities, raising capital, procuring new contracts, and
evaluating/structuring new acquisitions for the company.
1© Edgar Online, source Glimpses
US NUCLEAR CORP. 
